Inter-relationship between electrocardiographic left ventricular hypertrophy and qt prolongation as predictors of increased risk of mortality in the general population

Circulation: Arrhythmia and Electrophysiology

Volumn 7, Issue 3, 2014, Pages 400-406

  Soliman, Elsayed Z ^a   Shah, Amit J ^b   Boerkircher, Andrew ^c   Li, Yabing ^a   Rautaharju, Pentti M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

Electrocardiography; Left ventricular hypertrophy; Prolonged QT

Indexed keywords

ELECTROCARDIOGRAPHY; LEFT VENTRICULAR HYPERTROPHY; PROLONGED QT;

AGE DISTRIBUTION; AGED; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; DATABASES, FACTUAL; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; KAPLAN-MEIER ESTIMATE; LONG QT SYNDROME; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 84905816925     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.113.001396     Document Type: Article

References (27)

1. Soliman EZ, Howard G, Cushman M, Kissela B, Kleindorfer D, Le A, Judd S, McClure LA, Howard VJ. Prolongation of QTc and risk of stroke: the REGARDS (REasons for Geographic and Racial Differences in Stroke) study. J Am Coll Cardiol. 2012;59:1460-1467.
2. Dekker JM, Crow RS, Hannan PJ, Schouten EG, Folsom AR; ARIC Study. Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: the ARIC study. J Am Coll Cardiol. 2004;43:565-571.
3. Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, Deckers JW, Kingma JH, Sturkenboom MC, Stricker BH, Witteman JC. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47:362-367.
4. Sullivan JM, Vander Zwaag RV, el-Zeky F, Ramanathan KB, Mirvis DM. Left ventricular hypertrophy: effect on survival. J Am Coll Cardiol. 1993;22:508-513.
5. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566.
6. Winterton SJ, Turner MA, O'Gorman DJ, Flores NA, Sheridan DJ. Hypertrophy causes delayed conduction in human and guinea pig myocardium: accentuation during ischaemic perfusion. Cardiovasc Res. 1994;28:47-54.
7. McIntyre H, Fry CH. Abnormal action potential conduction in isolated human hypertrophied left ventricular myocardium. J Cardiovasc Electrophysiol. 1997;8:887-894.
8. Cooklin M, Wallis WR, Sheridan DJ, Fry CH. Changes in cell-to-cell electrical coupling associated with left ventricular hypertrophy. Circ Res. 1997;80:765-771.
9. Aronson RS. Characteristics of action potentials of hypertrophied myocardium from rats with renal hypertension. Circ Res. 1980;47:443-454.
10. Oikarinen L, Nieminen MS, Viitasalo M, Toivonen L, Wachtell K, Papademetriou V, Jern S, Dahlöf B, Devereux RB, Okin PM. Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. The Losartan Intervention For Endpoint Reduction. J Hypertens. 2001;19:1883-1891.
11. Johnson JN, Grifoni C, Bos JM, Saber-Ayad M, Ommen SR, Nistri S, Cecchi F, Olivotto I, Ackerman MJ. Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy. Eur Heart J. 2011;32:1114-1120.
12. Wong K Y, Lim PO, Wong SY, MacWalter RS, Struthers AD, MacDonald TM. Does a prolonged QT peak identify left ventricular hypertrophy in hypertension? Int J Cardiol. 2003;89:179-186.
13. Salles G, Leocádio S, Bloch K, Nogueira AR, Muxfeldt E. Combined QT interval and voltage criteria improve left ventricular hypertrophy detection in resistant hypertension. Hypertension. 2005;46:1207-1212.
14. Opadijo OG, Omotoso AB, Araoye MA. Ventricular arrhythmias: Q-T prolongation and left ventricular hypertrophy in adult Nigerians with hypertensive heart disease. Niger Postgrad Med J. 2003;10:76-78.
15. Panikkath R, Reinier K, Uy-Evanado A, Teodorescu C, Gunson K, Jui J, Chugh SS. Electrocardiographic predictors of sudden cardiac death in patients with left ventricular hypertrophy. Ann Noninvasive Electrocardiol. 2013;18:225-229.
16. Kang YJ. Cardiac hypertrophy: a risk factor for QT-prolongation and cardiac sudden death. Toxicol Pathol. 2006;34:58-66.
17. Soliman EZ, Cammarata M, Li Y. Explaining the inconsistent associations of PR interval with mortality: the role of P-duration contribution to the length of PR interval. Heart Rhythm. 2014;11:93-98.
18. Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R, Deal BJ, Gorgels A, Hancock EW, Josephson M, Kligfeld P, Kors JA, Macfarlane P, Mason JW, Mirvis DM, Okin P, Pahlm O, van Herpen G, Wagner GS, Wellens H. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientifc statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: Circulation. 2009;119:e241-e250.
19. Casale PN, Devereux RB, Alonso DR, Campo E, Kligfeld P. Improved sex-specifc criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy fnd-ings. Circulation. 1987;75:565-572.
20. Jain A, Tandri H, Dalal D, Chahal H, Soliman EZ, Prineas RJ, Folsom AR, Lima JA, Bluemke DA. Diagnostic and prognostic utility of elec-trocardiography for left ventricular hypertrophy defned by magnetic resonance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2010;159:652-658.
21. ten Eick RE, Whalley DW, Rasmussen HH. Connections: heart disease, cellular electrophysiology, and ion channels. FASEB J. 1992;6:2568-2580.
22. Frenneaux MP. Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy. Heart. 2004;90:570-575.
23. Kahan T, Bergfeldt L. Left ventricular hypertrophy in hypertension: its arrhythmogenic potential. Heart. 2005;91:250-256.
24. Swynghedauw B, Baillard C, Milliez P. The long QT interval is not only inherited but is also linked to cardiac hypertrophy. J Mol Med (Berl). 2003;81:336-345.
25. Eghbali M, Deva R, Alioua A, Minosyan TY, Ruan H, Wang Y, Toro L, Stefani E. Molecular and functional signature of heart hypertrophy during pregnancy. Circ Res. 2005;96:1208-1216.
26. Oikarinen L, Nieminen MS, Viitasalo M, Toivonen L, Jern S, Dahlöf B, Devereux RB, Okin PM; LIFE Study Investigators. QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension. 2004;43:1029-1034.
27. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm AJ, Cappato R, Cobbe SM, Di Mario C, Maron BJ, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P, Wellens HJ, Zipes DP. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2001;22:1374-1450.